Pharma Capital Ventures

Pharma Capital Ventures lacks the standard attributes of a family office in the public record. The entity shares a root domain with Stokes Tablet Press, a...

Pharma Capital Ventures

Pharma Capital Ventures lacks the standard attributes of a family office in the public record. The entity shares a root domain with Stokes Tablet Press, a supplier of re-manufactured tablet compression machines and replacement parts used in pharmaceutical production. No founding date, named operator, regulatory filing, or investment vehicle is attached to the name. The firm does not appear in EDGAR, state securities registries, or any known co-investment announcements. Without a disclosed mandate, the firm's strategy and deployment activity remain opaque. The associated operating business sells capital equipment to generic and specialty drug manufacturers, suggesting any adjacent capital deployment could theoretically touch pharmaceutical services, industrial automation, or small-scale manufacturing roll-ups. No portfolio companies, fund commitments, or direct investments are publicly linked to Pharma Capital Ventures. Scale and team composition cannot be verified. The operating entity, Stokes Tablet Press, is a small business with a narrow industrial footprint, likely sub-scale for institutional allocations. There are no LinkedIn profiles, press releases, or industry awards that clarify whether a dedicated investment team exists beyond what may be embedded in the operating company. Structurally, Pharma Capital Ventures may represent a lean family holding company wrapper around a single operating business rather than a diversified investment platform. If it functions as a family office at all, its posture is likely concentrated in a single industrial asset. Allocators should treat the entity as unreported private wealth until verified through direct outreach.

Website

stokestabletpress.com

General information

Firm type

Venture Capital

Year founded

—

AUM

Undisclosed

Location

Region

—

Country

—

City

—

Corporate office

—

What is the relationship between Pharma Capital Ventures and Stokes Tablet Press?

Pharma Capital Ventures operates on the same registered domain as Stokes Tablet Press, which re-manufactures and sells rotary tablet press machines and tooling for drug manufacturing. The nature of the ownership or investment structure between the two entities is not detailed in public filings.

Does Pharma Capital Ventures manage external capital?

There is no public record of Pharma Capital Ventures accepting external capital, registering as an investment advisor, or marketing fund interests to third-party investors. The entity pattern is consistent with an internally capitalized family vehicle.

Who makes investment decisions at Pharma Capital Ventures?

No named principals, investment committee members, or portfolio managers are publicly associated with Pharma Capital Ventures. The entity has no LinkedIn presence and has not appeared in trade publications identifying its leadership.

Has Pharma Capital Ventures made any disclosed direct investments or fund commitments?

No direct investments, venture rounds, private equity deals, or limited partner commitments have been publicly attributed to Pharma Capital Ventures. The firm name does not appear in any known transaction databases or SEC filings.

What is the likely source of wealth behind Pharma Capital Ventures?

The wealth origin is not publicly disclosed. Given the association with Stokes Tablet Press, the capital may derive from industrial profits in pharmaceutical manufacturing equipment sales and service, but this is not confirmed.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Jun 3, 2026. Continuous refresh with full update cycles at least every 30 days.